WHO Drug Information Vol. 25, No. 2, 2011

WHO Drug Information Vol. 25, No. 2, 2011 Proposed INN: List 105épelsibanepelsibán(3R,6R)-3-(2,3-dihydro-1H-indén-2-yl)-1-[(1R)-1-(2,6-diméthylpyridin-3-yl)-2-(morpholin-4-yl)-2-oxoéthyl]-6-[(2S)-butan-2-yl]pipérazine-2,5-dioneantagoniste de l'oxytocine(3R,6R)-3-(2,3-dihidro-1H-inden-2-il)-1-[(1R)-1-(2,6-dimetilpiridin-3-il)-2-(morfolin-4-il)-2-oxoetil]-6-[(2S)-butan-2-il]piperazina-2,5-dionaantagonista de la oxitocinaC 30 H 38 N 4 O 4 872599-83-2O HCH 3CH 3HNH OHONHNOH 3 CNCH 3etoxybamidumetoxybamideétoxybamideetoxibamida4-hydroxy-N-(2-hydroxyethyl)butanamidesedative, hypnotic4-hydroxy-N-(2-hydroxyéthyl)butanamidesédatif, hypnotique4-hidroxi-N-(2-hidroxietil)butanamidasedativo, hipnóticoC 6 H 13 NO 3 66857-17-8HOONHOHevacetrapibumevacetrapibévacétrapibevacetrapib(1r,4r)-4-({(5S)-5-[{[3,5-bis(trifluoromethyl)phenyl]methyl}(2-methyl-2H-tetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}methyl)cyclohexane-1-carboxylic acidantihyperlipidaemicacide (1r,4r)-4-({(5S)-5-[{[3,5-bis(trifluorométhyl)phényl]méthyl}(2-méthyl-2H-tétrazol-5-yl)amino]-7,9-diméthyl-2,3,4,5-tétrahydro-1H-benzazépin-1-yl}méthyl)cyclohexane-1-carboxyliqueantihyperlipidémiantácido (1r,4r)-4-({(5S)-5-[{[3,5-bis(trifluorometil)fenil]metil}(2-metil-2H-tetrazol-5-il)amino]-7,9-dimetil-2,3,4,5-tetrahidro-1H-1-benzazepin-1-il}metil)ciclohexano-1-carboxílicoantihiperlipémico169